224 related articles for article (PubMed ID: 8548746)
21. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of intercellular communication of rat hepatocytes by nafenopin: involvement of protein kinase C.
Leibold E; Greim H; Schwarz LR
Carcinogenesis; 1994 Jun; 15(6):1265-9. PubMed ID: 8020165
[TBL] [Abstract][Full Text] [Related]
23. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
Fahl WE; Lalwani ND; Reddy MK; Reddy JK
Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
[TBL] [Abstract][Full Text] [Related]
24. Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14 643 to DNA in vivo and in vitro.
Goel SK; Lalwani ND; Fahl WE; Reddy JK
Toxicol Lett; 1985 Jan; 24(1):37-43. PubMed ID: 2579476
[TBL] [Abstract][Full Text] [Related]
25. Methyl palmitate: inhibitor of phagocytosis in primary rat Kupffer cells.
Cai P; Kaphalia BS; Ansari GA
Toxicology; 2005 Jun; 210(2-3):197-204. PubMed ID: 15840433
[TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
[TBL] [Abstract][Full Text] [Related]
28. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
29. Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation.
Keller BJ; Marsman DS; Popp JA; Thurman RG
Biochim Biophys Acta; 1992 Sep; 1102(2):237-44. PubMed ID: 1390825
[TBL] [Abstract][Full Text] [Related]
30. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
31. Effect of the hepatocarcinogenic peroxisome proliferator Wy-14,643 in vivo: no increase in ethane exhalation or hepatic conjugated dienes.
Conway JG; Popp JA
Toxicol Appl Pharmacol; 1995 Dec; 135(2):229-36. PubMed ID: 8545832
[TBL] [Abstract][Full Text] [Related]
32. Growth regulation by peroxisome proliferators: opposing activities in early and late G1.
Ledwith BJ; Johnson TE; Wagner LK; Pauley CJ; Manam S; Galloway SM; Nichols WW
Cancer Res; 1996 Jul; 56(14):3257-64. PubMed ID: 8764118
[TBL] [Abstract][Full Text] [Related]
33. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
34. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.
Bojes HK; Germolec DR; Simeonova P; Bruccoleri A; Schoonhoven R; Luster MI; Thurman RG
Carcinogenesis; 1997 Apr; 18(4):669-74. PubMed ID: 9111198
[TBL] [Abstract][Full Text] [Related]
36. The effects of peroxisome proliferators on protein abundances in mouse liver.
Anderson NL; Esquer-Blasco R; Richardson F; Foxworthy P; Eacho P
Toxicol Appl Pharmacol; 1996 Mar; 137(1):75-89. PubMed ID: 8607144
[TBL] [Abstract][Full Text] [Related]
37. Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil.
Huber WW; Grasl-Kraupp B; Stekel H; Gschwentner C; Lang H; Schulte-Hermann R
Arch Toxicol; 1997; 71(9):575-81. PubMed ID: 9285040
[TBL] [Abstract][Full Text] [Related]
38. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
39. Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas.
Klaunig JE; Kamendulis LM
Toxicol Lett; 2005 Mar; 156(1):107-15. PubMed ID: 15705491
[TBL] [Abstract][Full Text] [Related]
40. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
